A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
SciTech Development, Inc.
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center